三維天地(301159.SZ):目前公司的產品仍舊採用項目制的銷售方式
格隆匯7月12日丨三維天地(301159.SZ)近期在接待機構投資者調研時表示,目前公司的產品仍舊採用項目制的銷售方式,盈利模式主要為主營業務軟件產品銷售與實施模式、運維服務模式、技術諮詢類項目模式等。具體開發及實施中,公司針對客户不同需求,在公司檢驗檢測信息化產品、數據資產管理產品原型上根據與客户簽訂的合同進行定製化開發,取得合同收入從而實現盈利。
隨着近年來數字經濟與數據要素政策頻出,公司也尋求在示範項目中探索嘗試其他盈利模式的機會,以期能夠跟上法規完善和技術進步的節奏,在未來豐富的數據應用場景下以適當的模式服務客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.